Ribavirin

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
RespiratoryInfectious Diseaseneeds review

Ribavirin

ATI class: Antiviral / Nucleoside analog

Action

  • ATI/source-folder candidate for Ribavirin; verify mechanism against the source table before validation.

Therapeutic use

  • Review under Upper Respiratory Tract Disorders medication safety.

Nursing assessment

  • Assess respiratory status, oxygenation, hydration, renal and hepatic risk, pregnancy status, and baseline CBC when ordered.
  • Monitor for anemia, fatigue, dyspnea, worsening respiratory status, and exposure precautions for pregnant caregivers if relevant.
  • Review route-specific administration precautions.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Hemolytic anemia
  • Teratogenicity risk
  • Respiratory irritation with aerosolized therapy
  • Fatigue

Interactions

  • Other myelosuppressive agents can increase anemia risk.
  • Antiretroviral combinations require source-specific interaction review.
  • Pregnancy exposure precautions are essential.

Contraindications

  • See source-specific contraindications and precautions before administration.

Precautions

  • Pregnancy or planned pregnancy unless source-specific specialist indication applies
  • Severe anemia
  • Significant renal or hepatic impairment requires review.

Client teaching

  • Use strict pregnancy prevention guidance as directed.
  • Report unusual fatigue, shortness of breath, chest pain, or signs of severe allergy.
  • Follow exact administration and exposure instructions.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • Breathing difficulty beats comfort symptoms.
  • Renal impairment can change dosing and toxicity risk.
  • Pregnancy exposure is a high-priority review cue.

Medication classes

Antivirals

Source attribution

Google Drive source topic: Upper Respiratory Tract Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Antivirals

Interferes with viral replication; exact target and timing depend on the antiviral.

ATI cueInteraction
Antiretroviral combinations require source-specific interaction review.

ATI medication interaction concept.

ATI cueClass
Antiviral

ATI medication class concept.

ATI cueNursing Assessment
Assess respiratory status, oxygenation, hydration, renal and hepatic risk, pregnancy status, and baseline CBC when ordered.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Ribavirin; verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueNCLEX Priority Cue
Breathing difficulty beats comfort symptoms.

ATI medication nclex priority cue concept.

ATI cueAdverse Effect
Fatigue

ATI medication adverse effect concept.

ATI cueClient Teaching
Follow exact administration and exposure instructions.

ATI medication client teaching concept.

ATI cueAdverse Effect
Hemolytic anemia

ATI medication adverse effect concept.

ATI cueNursing Assessment
Monitor for anemia, fatigue, dyspnea, worsening respiratory status, and exposure precautions for pregnant caregivers if relevant.

ATI medication nursing assessment concept.

ATI cueAntidote / Rescue
No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

ATI medication antidote / rescue concept.

ATI cueClass
Nucleoside analog

ATI medication class concept.